Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Navidea Biopharmaceuticals Announces First 110 Subjects Imaged In NAV3-35 Normative Database Phase 2b Study To Support Rheumatoid Arthritis Indications


Benzinga | Jul 19, 2021 07:31AM EDT

Navidea Biopharmaceuticals Announces First 110 Subjects Imaged In NAV3-35 Normative Database Phase 2b Study To Support Rheumatoid Arthritis Indications






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC